Newswise News from La Jolla Institute for Immunology display Latest news from La Jolla Institute for Immunology on Newswise en-us Copyright 2024 Newswise Newswise News from La Jolla Institute for Immunology 115 31 / /images/newswise-logo-rss.gif La Jolla Institute for Immunology Launches New International Research Partnership with Link Campus University /articles/la-jolla-institute-for-immunology-launches-new-international-research-partnership-with-link-campus-university/?sc=rsin /articles/la-jolla-institute-for-immunology-launches-new-international-research-partnership-with-link-campus-university/?sc=rsin Tue, 19 Nov 2024 12:25:50 EST La Jolla Institute for Immunology (LJI) and Link Campus University of Rome, Italy, and have signed a collaborative agreement as part of a strategic program aimed at promoting scientific research and innovation between the United States and Italy. La Jolla Institute for Immunology Update: San Diego scientist available to comment on dengue vaccine research -- following report of second locally transmitted dengue case /articles/update-san-diego-scientist-available-to-comment-on-dengue-vaccine-research-following-report-of-second-locally-transmitted-dengue-case/?sc=rsin /articles/update-san-diego-scientist-available-to-comment-on-dengue-vaccine-research-following-report-of-second-locally-transmitted-dengue-case/?sc=rsin Tue, 29 Oct 2024 12:25:35 EST La Jolla Institute for Immunology Expert Alert: San Diego Scientist Available to Comment on Local Dengue Case /articles/expert-alert-san-diego-scientist-available-to-comment-on-local-dengue-case/?sc=rsin /articles/expert-alert-san-diego-scientist-available-to-comment-on-local-dengue-case/?sc=rsin Thu, 10 Oct 2024 11:05:39 EST LA JOLLA, CA--La Jolla Institute for Immunology (LJI) Professor Sujan Shresta, Ph.D., is on hand to share her expertise on dengue fever and dengue vaccine development. She is available to comment on urgent dengue virus research amidst the news of San Diego's first locally acquired dengue virus case. LJI Professor Sujan Shresta, Ph. La Jolla Institute for Immunology LJI Discovery Paves the Way for Antivirals Against Ebola Virus and Its Deadly Relatives /articles/lji-discovery-paves-the-way-for-antivirals-against-ebola-virus-and-its-deadly-relatives/?sc=rsin /articles/lji-discovery-paves-the-way-for-antivirals-against-ebola-virus-and-its-deadly-relatives/?sc=rsin Tue, 17 Sep 2024 17:05:16 EST The new study, led by researchers in the Saphire Lab at LJI, reveals the inner workings of the Ebola virus nucleocapsid. LA JOLLA, CA--At this moment, the world has few tools to combat deadly filoviruses, such as Ebola and Marburg viruses. The only approved vaccine and antibody treatments protect against just one filovirus species. La Jolla Institute for Immunology T cells may offer some protection in an H5N1 'spillover' scenario /articles/t-cells-may-offer-some-protection-in-an-h5n1-spillover-scenario/?sc=rsin /articles/t-cells-may-offer-some-protection-in-an-h5n1-spillover-scenario/?sc=rsin Mon, 16 Sep 2024 13:05:34 EST The LJI team uncovered important similarities between H5N1 and these common viruses, which allowed them to predict that many people already have "cross-reactive" T cells that are ready to target H5N1--should it ever mutate to cause widespread disease in humans. La Jolla Institute for Immunology LJI Selected as Member of ARPA-H Investor Catalyst Hub Spoke Network /articles/lji-selected-as-member-of-arpa-h-investor-catalyst-hub-spoke-network/?sc=rsin /articles/lji-selected-as-member-of-arpa-h-investor-catalyst-hub-spoke-network/?sc=rsin Wed, 11 Sep 2024 12:05:47 EST La Jolla Institute for Immunology (LJI) has been selected as a spoke for the Investor Catalyst Hub, a regional hub of ARPANET-H, a nationwide health innovation network launched by the Advanced Research Projects Agency for Health (ARPA-H). La Jolla Institute for Immunology LJI scientists lead new mpox research /articles/lji-scientists-lead-new-mpox-research/?sc=rsin /articles/lji-scientists-lead-new-mpox-research/?sc=rsin Thu, 22 Aug 2024 13:05:32 EST Scientists at La Jolla Institute for Immunology (LJI) are investigating how the mutated clade 1 mpox virus may affect children and older patients--and how new vaccines can help the body fight back. La Jolla Institute for Immunology San Diego scientists available to discuss mutated mpox strain /articles/san-diego-scientists-available-to-discuss-mutated-mpox-strain/?sc=rsin /articles/san-diego-scientists-available-to-discuss-mutated-mpox-strain/?sc=rsin Thu, 22 Aug 2024 12:05:14 EST La Jolla Institute for Immunology Sydney Ramirez receives prestigious Burroughs Wellcome Fund Career Award /articles/sydney-ramirez-receives-prestigious-burroughs-wellcome-fund-career-award/?sc=rsin /articles/sydney-ramirez-receives-prestigious-burroughs-wellcome-fund-career-award/?sc=rsin Thu, 20 Jun 2024 10:05:47 EST "As an infectious diseases clinician, I've always been focused on research into pathogen-host interactions. We need to know why some people get sicker than others." La Jolla Institute for Immunology New research points to 'stem-like' T cells as culprits in ulcerative colitis /articles/new-research-points-to-stem-like-t-cells-as-culprits-in-ulcerative-colitis/?sc=rsin /articles/new-research-points-to-stem-like-t-cells-as-culprits-in-ulcerative-colitis/?sc=rsin Wed, 19 Jun 2024 05:00:00 EST The researchers hope to one day target this T cell population via drug therapy. "These cells may be a very important target for treating ulcerative colitis and perhaps other autoimmune diseases..." La Jolla Institute for Immunology LJI scientists develop new method to match genes to their molecular 'switches' /articles/lji-scientists-develop-new-method-to-match-genes-to-their-molecular-8216-switches8217/?sc=rsin /articles/lji-scientists-develop-new-method-to-match-genes-to-their-molecular-8216-switches8217/?sc=rsin Mon, 03 Jun 2024 13:05:51 EST LA JOLLA, CA--Scientists at La Jolla Institute for Immunology (LJI) have developed a new computational method for linking molecular marks on our DNA to gene activity. Their work may help researchers connect genes to the molecular "switches" that turn them on or off. This research, published in Genome Biology, is an important step toward harnessing machine learning approaches to better understand links between gene expression and disease development. La Jolla Institute for Immunology How COVID-19 'breakthrough' infections alter your immune cells /articles/how-covid-19-breakthrough-infections-alter-your-immune-cells/?sc=rsin /articles/how-covid-19-breakthrough-infections-alter-your-immune-cells/?sc=rsin Fri, 24 May 2024 12:05:47 EST Repeated vaccination and infection leads T cells and B cells to build an "immunity wall" La Jolla Institute for Immunology LJI scientist Alison Tarke honored by Italian government /articles/lji-scientist-alison-tarke-honored-by-italian-government/?sc=rsin /articles/lji-scientist-alison-tarke-honored-by-italian-government/?sc=rsin Tue, 07 May 2024 12:05:43 EST "Alison's research has been very, very impactful, and her efforts have catalyzed a cultural exchange between the United State and Italy." La Jolla Institute for Immunology Researchers reveal how protein modifications power T cells /articles/researchers-reveal-how-protein-modifications-power-t-cells/?sc=rsin /articles/researchers-reveal-how-protein-modifications-power-t-cells/?sc=rsin Mon, 29 Apr 2024 13:05:26 EST This method is a major leap forward for scientists investigating how proteins do their jobs in the immune system. "This method basically creates an entire new kind of world of experiments that people can do..." La Jolla Institute for Immunology LJI home to new "Center of Excellence" /articles/lji-home-to-new-center-of-excellence/?sc=rsin /articles/lji-home-to-new-center-of-excellence/?sc=rsin Wed, 17 Apr 2024 12:05:40 EST The Institute's Flow Cytometry Core, which provides cutting-edge research services, has been named a BD Biosciences "Center of Excellence." Along with this distinction, the LJI Flow Core has brought in a sophisticated instrument for immune cell research: the BD FACSDiscover(tm) S8 Cell Sorter. La Jolla Institute for Immunology Vac to the future /articles/vac-to-the-future/?sc=rsin /articles/vac-to-the-future/?sc=rsin Thu, 14 Mar 2024 15:05:41 EST "We are hoping to use this competition not just as a way to examine the capacity of people to predict vaccination outcomes, but also as a way to address an important public health question," says Peters. La Jolla Institute for Immunology LJI welcomes new faculty member Miguel Reina-Campos, Ph.D. /articles/lji-welcomes-new-faculty-member-miguel-reina-campos-ph-d/?sc=rsin /articles/lji-welcomes-new-faculty-member-miguel-reina-campos-ph-d/?sc=rsin Fri, 01 Mar 2024 00:05:49 EST Cancer researcher Miguel Reina-Campos, Ph.D., has joined the faculty of La Jolla Institute for Immunology (LJI) as an Assistant Professor to lead the Laboratory of Tissue Immune Networks. His laboratory at LJI aims to investigate the basis of CD8+ T cell tissue immunity to improve life-saving cancer immunotherapies. La Jolla Institute for Immunology How T cells combat tuberculosis /articles/how-t-cells-combat-tuberculosis/?sc=rsin /articles/how-t-cells-combat-tuberculosis/?sc=rsin Tue, 06 Feb 2024 11:05:30 EST Scientists at La Jolla Institute for Immunology (LJI) have uncovered important clues to how human T cells combat the bacterium that causes tuberculosis. La Jolla Institute for Immunology How 'late-rising' T cells combat a stubborn virus /articles/how-late-rising-t-cells-combat-a-stubborn-virus/?sc=rsin /articles/how-late-rising-t-cells-combat-a-stubborn-virus/?sc=rsin Thu, 18 Jan 2024 15:05:37 EST "We found sort of a special 'flavor' of CD4+ T cells critical for clearing this chronic virus replication," La Jolla Institute for Immunology Researchers discover potentially cancer-fighting T cells within some pediatric brain tumor patients /articles/researchers-discover-potentially-cancer-fighting-t-cells-within-some-pediatric-brain-tumor-patients/?sc=rsin /articles/researchers-discover-potentially-cancer-fighting-t-cells-within-some-pediatric-brain-tumor-patients/?sc=rsin Thu, 18 Jan 2024 14:05:58 EST "These patients may be candidates in whom immunotherapy has the potential to show clinical benefit." La Jolla Institute for Immunology